A detailed history of National Bank Of Canada transactions in Eli Lilly & CO stock. As of the latest transaction made, National Bank Of Canada holds 646,036 shares of LLY stock, worth $514 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares
646,036
Previous 646,036 -0.0%
Holding current value
$514 Million
Previous $572 Million -0.0%
% of portfolio
0.79%
Previous 0.79%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $32.3 Million - $40.1 Million
41,803 Added 6.92%
646,036 $572 Million
Q2 2024

Aug 02, 2024

BUY
$724.87 - $909.04 $109 Million - $136 Million
150,043 Added 33.04%
604,233 $547 Million
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $70.2 Million - $93.9 Million
118,520 Added 35.31%
454,190 $353 Million
Q4 2023

Feb 06, 2024

SELL
$525.19 - $619.13 $26.3 Million - $31 Million
-50,059 Reduced 12.98%
335,670 $196 Million
Q3 2023

Oct 10, 2023

BUY
$434.7 - $599.3 $57.7 Million - $79.5 Million
132,649 Added 52.41%
385,729 $207 Million
Q2 2023

Jul 26, 2023

BUY
$350.74 - $468.98 $40.8 Million - $54.5 Million
116,253 Added 84.96%
253,080 $119 Million
Q1 2023

Apr 12, 2023

BUY
$310.63 - $364.82 $6.08 Million - $7.14 Million
19,565 Added 16.68%
136,827 $47 Million
Q4 2022

Jan 24, 2023

BUY
$321.55 - $374.67 $6.18 Million - $7.2 Million
19,217 Added 19.6%
117,262 $0
Q3 2022

Oct 13, 2022

SELL
$296.48 - $337.87 $56 Million - $63.8 Million
-188,858 Reduced 65.83%
98,045 $31.5 Million
Q2 2022

Jul 28, 2022

BUY
$278.73 - $327.27 $49.6 Million - $58.2 Million
177,961 Added 163.35%
286,903 $93 Million
Q1 2022

May 05, 2022

BUY
$234.69 - $291.66 $2.35 Million - $2.92 Million
10,005 Added 10.11%
108,942 $31.3 Million
Q4 2021

Jan 24, 2022

BUY
$224.85 - $279.04 $22.2 Million - $27.6 Million
98,937 New
98,937 $27.3 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.